OCREVUS

Google image searchProduct monograph

Active ingredient

ocrelizumab, 30 MG/ML

DIN: 02467224

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 21-SEP-2017

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AG — Monoclonal antibodies (ATC, ATC/DDD)
• L04AG08 — OCRELIZUMAB (ATC/DDD)

External Links for Ocrevus

Search on Google

• Ocrevus side effects
• Ocrevus dosage
• ocrelizumab side effects
• ocrelizumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find ocrevus photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.